MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell–Intrinsic and Host-Dependent Mechanisms

Por Felsher, Dean W.
Publicado em 2010

Transient excess of MYC activity can elicit genomic instability and tumorigenesis

Por Felsher, Dean W., Bishop, J. Michael
Publicado em 1999

MYC Activation Is a Hallmark of Cancer Initiation and Maintenance

Por Gabay, Meital, Li, Yulin, Felsher, Dean W.
Publicado em 2014

Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance

Por Choi, Peter S., Li, Yulin, Felsher, Dean W.
Publicado em 2014

Oncogene addiction: resetting the safety switch?

Por Li, Yulin, Choi, Peter S., Felsher, Dean W.
Publicado no Oncotarget (2014)

BIM-mediated apoptosis and oncogene addiction

Por Li, Yulin, Deutzmann, Anja, Felsher, Dean W.
Publicado no Aging (Albany NY) (2016)

Tumor Dormancy, Oncogene Addiction, Cellular Senescence and Self-Renewal Programs

Por Bellovin, David I., Das, Bikul, Felsher, Dean W.
Publicado em 2013

Inactivation of MYC reverses tumorigenesis

Por Li, Yulin, Casey, Stephanie C., Felsher, Dean W.
Publicado em 2014

An Essential Role for the Immune System in the Mechanism of Tumor Regression Following Targeted Oncogene Inactivation

Por Casey, Stephanie C., Li, Yulin, Felsher, Dean W.
Publicado em 2014

MYC: Master Regulator of Immune Privilege

Por Casey, Stephanie C., Baylot, Virginie, Felsher, Dean W.
Publicado no Trends Immunol (2017)

Noncanonical Roles of the Immune System in Eliciting Oncogene Addiction

Por Casey, Stephanie C., Bellovin, David I., Felsher, Dean W.
Publicado em 2013

Metabolic vulnerabilities of MYC-induced cancer

Por Gouw, Arvin M., Toal, Georgia G., Felsher, Dean W.
Publicado no Oncotarget (2016)

Activation of Cre Recombinase Alone Can Induce Complete Tumor Regression

Por Li, Yulin, Choi, Peter S., Casey, Stephanie C., Felsher, Dean W.
Publicado em 2014

A Tumor-Immune Mathematical Model of CD4+ T Helper Cell Dependent Tumor Regression by Oncogene Inactivation

Por Nwabugwu, Chinyere I., Rahra, Kavya, Felsher, Dean W., Paik, David S.
Publicado no Conf Proc IEEE Eng Med Biol Soc (2013)

ARF: Connecting senescence and innate immunity for clearance

Por Kearney, Alper Y., Anchang, Benedict, Plevritis, Sylvia, Felsher, Dean W.
Publicado no Aging (Albany NY) (2015)

miR-17–92 explains MYC oncogene addiction

Por Li, Yulin, Casey, Stephanie C, Choi, Peter S, Felsher, Dean W
Publicado no Mol Cell Oncol (2014)

Oncogene withdrawal engages the immune system to induce sustained cancer regression

Por Casey, Stephanie C, Li, Yulin, Fan, Alice C, Felsher, Dean W
Publicado em 2014

Overexpression of MYC causes p53-dependent G(2) arrest of normal fibroblasts

Por Felsher, Dean W., Zetterberg, Anders, Zhu, Jiyue, Tlsty, Thea, Bishop, J. Michael
Publicado em 2000

Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma

Por Saddic, Louis A., Wirt, Stacey, Vogel, Hannes, Felsher, Dean W., Sage, Julien
Publicado em 2011

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia

Por Li, Yulin, Deutzmann, Anja, Choi, Peter S., Fan, Alice C., Felsher, Dean W.
Publicado no Oncotarget (2016)